187 related articles for article (PubMed ID: 23281834)
1. Blocking protein kinase C signaling pathway: mechanistic insights into the anti-leishmanial activity of prospective herbal drugs from Withania somnifera.
Grover A; Katiyar SP; Jeyakanthan J; Dubey VK; Sundar D
BMC Genomics; 2012; 13 Suppl 7(Suppl 7):S20. PubMed ID: 23281834
[TBL] [Abstract][Full Text] [Related]
2. Homology modelling, molecular docking, and molecular dynamics simulations reveal the inhibition of Leishmania donovani dihydrofolate reductase-thymidylate synthase enzyme by Withaferin-A.
Vadloori B; Sharath AK; Prabhu NP; Maurya R
BMC Res Notes; 2018 Apr; 11(1):246. PubMed ID: 29661206
[TBL] [Abstract][Full Text] [Related]
3. Withanolides from
Khanal P; Chikhale R; Dey YN; Pasha I; Chand S; Gurav N; Ayyanar M; Patil BM; Gurav S
J Biomol Struct Dyn; 2022 Aug; 40(12):5295-5308. PubMed ID: 33459174
[TBL] [Abstract][Full Text] [Related]
4. Withanolides against TLR4-Activated Innate Inflammatory Signalling Pathways: A Comparative Computational and Experimental Study.
Purushotham PM; Kim JM; Jo EK; Senthil K
Phytother Res; 2017 Jan; 31(1):152-163. PubMed ID: 27859734
[TBL] [Abstract][Full Text] [Related]
5. In Silico Elucidation of the Plausible Inhibitory Potential of Withaferin A of Withania Somnifera Medicinal Herb Against Breast Cancer Targeting Estrogen Receptor.
Ali MA; Farah MA; Al-Anazi KM; Basha SH; Bai F; Lee J; Al-Hemaid FMA; Mahmoud AH; Hailan WAQ
Curr Pharm Biotechnol; 2020; 21(9):842-851. PubMed ID: 31995002
[TBL] [Abstract][Full Text] [Related]
6. Differential activities of the two closely related withanolides, Withaferin A and Withanone: bioinformatics and experimental evidences.
Vaishnavi K; Saxena N; Shah N; Singh R; Manjunath K; Uthayakumar M; Kanaujia SP; Kaul SC; Sekar K; Wadhwa R
PLoS One; 2012; 7(9):e44419. PubMed ID: 22973447
[TBL] [Abstract][Full Text] [Related]
7. Epoxide group relationship with cytotoxicity in withanolide derivatives from Withania somnifera.
Joshi P; Misra L; Siddique AA; Srivastava M; Kumar S; Darokar MP
Steroids; 2014 Jan; 79():19-27. PubMed ID: 24184562
[TBL] [Abstract][Full Text] [Related]
8. Mechanistic insights into mode of actions of novel oligopeptidase B inhibitors for combating leishmaniasis.
Goyal S; Grover S; Dhanjal JK; Goyal M; Tyagi C; Chacko S; Grover A
J Mol Model; 2014 Mar; 20(3):2099. PubMed ID: 24567150
[TBL] [Abstract][Full Text] [Related]
9. Leishmanicidal active withanolides from a pakistani medicinal plant, Withania coagulans.
Kuroyanagi M; Murata M; Nakane T; Shirota O; Sekita S; Fuchino H; Shinwari ZK
Chem Pharm Bull (Tokyo); 2012; 60(7):892-7. PubMed ID: 22790824
[TBL] [Abstract][Full Text] [Related]
10. Molecular docking and dynamic simulation studies evidenced plausible immunotherapeutic anticancer property by Withaferin A targeting indoleamine 2,3-dioxygenase.
Reddy SV; Reddy KT; Kumari VV; Basha SH
J Biomol Struct Dyn; 2015; 33(12):2695-709. PubMed ID: 25671592
[TBL] [Abstract][Full Text] [Related]
11. Computational Identification of BCR-ABL Oncogenic Signaling as a Candidate Target of Withaferin A and Withanone.
Malik V; Radhakrishnan N; Kaul SC; Wadhwa R; Sundar D
Biomolecules; 2022 Jan; 12(2):. PubMed ID: 35204712
[TBL] [Abstract][Full Text] [Related]
12. Synthesis,
Gaurav I; Singh T; Thakur A; Kumar G; Rathee P; Kumari P; Sweta K
Curr Pharm Biotechnol; 2020; 21(15):1674-1687. PubMed ID: 32614743
[TBL] [Abstract][Full Text] [Related]
13. Hedgehog inhibitors from Withania somnifera.
Yoneyama T; Arai MA; Sadhu SK; Ahmed F; Ishibashi M
Bioorg Med Chem Lett; 2015 Sep; 25(17):3541-4. PubMed ID: 26169123
[TBL] [Abstract][Full Text] [Related]
14. 5,6-de-epoxy-5-en-7-one-17-hydroxy withaferin A, a new cytotoxic steroid from Withania somnifera L. Dunal leaves.
Siddique AA; Joshi P; Misra L; Sangwan NS; Darokar MP
Nat Prod Res; 2014; 28(6):392-8. PubMed ID: 24422976
[TBL] [Abstract][Full Text] [Related]
15. Structural insights into the enzymes of the trypanothione pathway: targets for antileishmaniasis drugs.
Colotti G; Baiocco P; Fiorillo A; Boffi A; Poser E; Chiaro FD; Ilari A
Future Med Chem; 2013 Oct; 5(15):1861-75. PubMed ID: 24144416
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of the NEMO/IKKβ association complex formation, a novel mechanism associated with the NF-κB activation suppression by Withania somnifera's key metabolite withaferin A.
Grover A; Shandilya A; Punetha A; Bisaria VS; Sundar D
BMC Genomics; 2010 Dec; 11 Suppl 4(Suppl 4):S25. PubMed ID: 21143809
[TBL] [Abstract][Full Text] [Related]
17. Promising Anti-influenza Properties of Active Constituent of Withania somnifera Ayurvedic Herb in Targeting Neuraminidase of H1N1 Influenza: Computational Study.
Cai Z; Zhang G; Tang B; Liu Y; Fu X; Zhang X
Cell Biochem Biophys; 2015 Jul; 72(3):727-39. PubMed ID: 25627548
[TBL] [Abstract][Full Text] [Related]
18. Identification of Potential
Orabi MAA; Alshahrani MM; Sayed AM; Abouelela ME; Shaaban KA; Abdel-Sattar ES
Metabolites; 2023 Jan; 13(1):. PubMed ID: 36677018
[TBL] [Abstract][Full Text] [Related]
19. Optimization of carbon source for hairy root growth and withaferin A and withanone production in Withania somnifera.
Sivanandhan G; Rajesh M; Arun M; Jeyaraj M; Dev GK; Manickavasagam M; Selvaraj N; Ganapathi A
Nat Prod Commun; 2012 Oct; 7(10):1271-2. PubMed ID: 23156987
[TBL] [Abstract][Full Text] [Related]
20. Flavones reversibly inhibit Leishmania donovani tyrosine aminotransferase by binding to the catalytic pocket: An integrated in silico-in vitro approach.
Sasidharan S; Saudagar P
Int J Biol Macromol; 2020 Dec; 164():2987-3004. PubMed ID: 32798546
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
